ArticleDrug testing and analysis2023
Cannabinoid-based vaping products and supplement formulations reported by consumers to precipitate adverse effects.
Article in Drug testing and analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 15 citations in OpenAlex.
- Cannabidiol at the crossroads: panacea, placebo, or problem?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Review
- Fast and reliable in vitro activity-based detection of synthetic cannabinoid receptor agonists in e-liquids.Archives of toxicology · 2026Article
- Cannabinoid Vaping Products: Regulation, Composition, Toxicological Effects, and Emerging Research.Chemical research in toxicology · 2025Review
- Vaping-induced Oxidation of Cannabidiol Causes Adduction of TOP2A and Interferes with Cellular Proliferation.American journal of respiratory cell and molecular biology · 2025Article
- Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-Cigarettes.ACS omega · 2025Article
- A multi-year characterization of confiscated vaping products from Virginia school youth.Journal of analytical toxicology · 2024Article
- Activity-based detection of synthetic cannabinoid receptor agonists in plant materials.Harm reduction journal · 2024Article
- The history, evolution, and practice of cannabis and E-cigarette industries highlight necessary public health and public safety considerations.Journal of safety research · 2023Article
- ∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles.Journal of analytical toxicology · 2022Article
- Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine.Journal of psychoactive drugsArticle
Corrections and comments
- Commented on by
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
Cannabinoid-based products submitted by consumers experiencing adverse effects were analyzed to identify and quantitate ingredients. Product testing identified several synthetic cannabinoids and products with inaccurate or incomplete labeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.